Eintrag weiter verarbeiten
The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment
Gespeichert in:
| Zeitschriftentitel: | Journal of Thrombosis and Haemostasis |
|---|---|
| Personen und Körperschaften: | , |
| In: | Journal of Thrombosis and Haemostasis, 15, 2017, 12, S. 2466-2467 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Elsevier BV
|
| Schlagwörter: |
| author_facet |
Yip, L. Deng, J.‐F. Yip, L. Deng, J.‐F. |
|---|---|
| author |
Yip, L. Deng, J.‐F. |
| spellingShingle |
Yip, L. Deng, J.‐F. Journal of Thrombosis and Haemostasis The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment Hematology |
| author_sort |
yip, l. |
| spelling |
Yip, L. Deng, J.‐F. 1538-7836 Elsevier BV Hematology http://dx.doi.org/10.1111/jth.13854 The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment Journal of Thrombosis and Haemostasis |
| doi_str_mv |
10.1111/jth.13854 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qdGguMTM4NTQ |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qdGguMTM4NTQ |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
Elsevier BV, 2017 |
| imprint_str_mv |
Elsevier BV, 2017 |
| issn |
1538-7836 |
| issn_str_mv |
1538-7836 |
| language |
English |
| mega_collection |
Elsevier BV (CrossRef) |
| match_str |
yip2017therecommendeddoseofidarucizumabmaynotalwaysbesufficientforsustainedreversalofdabigatrancomment |
| publishDateSort |
2017 |
| publisher |
Elsevier BV |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of Thrombosis and Haemostasis |
| source_id |
49 |
| title |
The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
| title_unstemmed |
The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
| title_full |
The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
| title_fullStr |
The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
| title_full_unstemmed |
The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
| title_short |
The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
| title_sort |
the recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
| topic |
Hematology |
| url |
http://dx.doi.org/10.1111/jth.13854 |
| publishDate |
2017 |
| physical |
2466-2467 |
| description |
|
| container_issue |
12 |
| container_start_page |
2466 |
| container_title |
Journal of Thrombosis and Haemostasis |
| container_volume |
15 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792329476768530444 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T13:09:48.346Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=The+recommended+dose+of+idarucizumab+may+not+always+be+sufficient+for+sustained+reversal+of+dabigatran%3A+comment&rft.date=2017-12-01&genre=article&issn=1538-7836&volume=15&issue=12&spage=2466&epage=2467&pages=2466-2467&jtitle=Journal+of+Thrombosis+and+Haemostasis&atitle=The+recommended+dose+of+idarucizumab+may+not+always+be+sufficient+for+sustained+reversal+of+dabigatran%3A+comment&aulast=Deng&aufirst=J.%E2%80%90F.&rft_id=info%3Adoi%2F10.1111%2Fjth.13854&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792329476768530444 |
| author | Yip, L., Deng, J.‐F. |
| author_facet | Yip, L., Deng, J.‐F., Yip, L., Deng, J.‐F. |
| author_sort | yip, l. |
| container_issue | 12 |
| container_start_page | 2466 |
| container_title | Journal of Thrombosis and Haemostasis |
| container_volume | 15 |
| description | |
| doi_str_mv | 10.1111/jth.13854 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qdGguMTM4NTQ |
| imprint | Elsevier BV, 2017 |
| imprint_str_mv | Elsevier BV, 2017 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 1538-7836 |
| issn_str_mv | 1538-7836 |
| language | English |
| last_indexed | 2024-03-01T13:09:48.346Z |
| match_str | yip2017therecommendeddoseofidarucizumabmaynotalwaysbesufficientforsustainedreversalofdabigatrancomment |
| mega_collection | Elsevier BV (CrossRef) |
| physical | 2466-2467 |
| publishDate | 2017 |
| publishDateSort | 2017 |
| publisher | Elsevier BV |
| record_format | ai |
| recordtype | ai |
| series | Journal of Thrombosis and Haemostasis |
| source_id | 49 |
| spelling | Yip, L. Deng, J.‐F. 1538-7836 Elsevier BV Hematology http://dx.doi.org/10.1111/jth.13854 The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment Journal of Thrombosis and Haemostasis |
| spellingShingle | Yip, L., Deng, J.‐F., Journal of Thrombosis and Haemostasis, The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment, Hematology |
| title | The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
| title_full | The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
| title_fullStr | The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
| title_full_unstemmed | The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
| title_short | The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
| title_sort | the recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
| title_unstemmed | The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment |
| topic | Hematology |
| url | http://dx.doi.org/10.1111/jth.13854 |